drugset / Trial / NCT02641860

Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

NCT02641860 ↗

Phase 1 Completed 22 enrolled Shanghai AbelZeta Ltd. RenJi Hospital · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the safety and efficacy of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis.

Timeline

Start
2015-12
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal progenitor cells Cell therapy 1e+07 cells Other
Subject Mesenchymal progenitor cells Cell therapy 2e+07 cells Other
Subject Mesenchymal progenitor cells Cell therapy 5e+07 cells Other

Indications